Skip to main content
ByMarch 31, 2026~17 min read

Golden House 2025: Operations Recovered, but Part of the Jump Is Still Temporary

Golden House ended 2025 with 22.7% revenue growth, a sharp rise in NOI and better occupancy. But beneath the recovery, the company still depends on one asset, relies materially on non-permanent occupancy, and has not yet turned its post-distribution strategy into a cleaner long-term story.

Company Introduction

Golden House is no longer a multi-asset elderly-care group. After monetizing the England activity and selling Seven Stars, it is now essentially a one-asset company built around Beit Gil Hazahav in Tel Aviv, plus the commercial space inside the complex. That matters because the right way to read the filing is no longer through diversification. It is through the economics of a single property with assisted-living, nursing and commercial layers sitting on top of each other.

What is working now is real. Revenue rose in 2025 to NIS 48.9 million from NIS 39.8 million in 2024, gross profit rose to NIS 20.9 million from NIS 16.6 million, operating profit jumped to NIS 14.0 million from NIS 5.1 million, and FFO under the Israeli Securities Authority approach rose to NIS 11.6 million from NIS 5.0 million. At the asset level, NOI rose to NIS 17.3 million from NIS 13.3 million, average monthly payment per unit rose to NIS 10,038, and average occupancy rose to 75% from 64.3%.

But the superficial read is still misleading. The house looks fuller than its permanent economics really are. During 2025, about 281 apartments were occupied on average, roughly 95% total occupancy, yet around 59 of them on average, about 20%, were occupied by tenants who were not permanent assisted-living residents. At year end that number was still 52 apartments. Revenue from this type of occupancy reached about NIS 2.7 million. In other words, the recovery is real, but part of it still rests on a bridge solution.

That is the active bottleneck in the story. Golden House proved in 2025 that it can improve operations, pricing and occupancy. It has not yet proved that this occupancy has become a clean, permanent resident base that no longer needs the bridge. At the same time, this is still a one-asset company with an imperfect rights structure: 78 of the building's 390 rooms, together with 20% of the public areas, belong to Koptash and are leased in. Anyone looking only at the property value or the book equity and immediately concluding "discount" is missing the access-to-value layer.

The early investor screen is fairly sharp. As of April 6, 2026, market cap stood around NIS 163 million, while turnover on the latest trading day was just NIS 878. That is not a side note. It is a real actionability constraint. On the other hand, short interest is negligible: short float stood at 0.00% at the end of March, with SIR of 0.04. So this is not a technical short story. It is a story about recovery quality, one-asset concentration and capital allocation after the large 2025 distribution.

Golden House's Economic Map

LayerKey factWhy it matters
Core business296 assisted-living units, a 36-bed nursing department, and commercial space in the complexThe company's economics are determined almost entirely by one campus
Rights structure80% effective ownership in the asset, while 78 rooms and 20% of the public space are leased from KoptashProperty value does not automatically equal value accessible to common shareholders
Operating base121 employees at year end and about NIS 404 thousand of revenue per employeeThis is a real operating platform, not just passive real estate
Balance sheetNIS 81.8 million cash, NIS 17.9 million securities, NIS 63.7 million bonds, and NIS 270.8 million equityThere is no immediate balance-sheet stress, but the capital-allocation question is open
Market setupAround NIS 163 million market cap, negligible daily liquidity, and almost no short interestThe gap between market value and equity is mainly a quality and accessibility question
2024 vs 2025: operating recovery returned

Events And Triggers

The first trigger: the 2025 recovery is not merely accounting. Management ties it to higher occupancy in assisted living and in the nursing department, a larger share of residents on the monthly-rent route rather than deposit or entrance-fee routes, and the transition to operating the in-house restaurant independently. That matters because the improvement came from the operating floor, not just from revaluation.

The second trigger: the same recovery still leans partly on temporary occupancy. This is the difference between a house that looks full and a house that already sits on a strong permanent economic base. The 75% average occupancy is the number that matters economically, not only the 95% total occupancy picture. As long as the house still needs dozens of units filled by non-permanent tenants, the story is one of recovery, not of arrival.

The third trigger: after the 2024 monetizations and the NIS 195 million dividend paid in April 2025, the board established a strategy committee that by March 29, 2026 had already published interim recommendations. Those recommendations say a lot about where the company stands. On one hand, push occupancy above 90%, upgrade public areas and keep investing in branding. On the other hand, re-examine new activity areas in Israel and abroad, including assisted living, healthcare and real estate. That is an implicit admission that 2025 did not yet create a new strategic chapter. It mainly cleared the table for one.

The fourth trigger: on March 29, 2026, Efi Katz was also appointed the company's senior finance officer, after already serving for years as deputy CEO and previously as projects executive. That alone does not change the thesis, but it does signal that the company is moving from a monetization-and-distribution phase into one where financial discipline and capital allocation come back to the center.

The fifth trigger: the Seven Stars story is not closed. Beyond the purchase-price adjustment dispute, which could still bring Golden House an early payment of about NIS 2.7 million less whatever amount is decided by the accountant process, a NIS 15 million lawsuit was filed against the company and its CEO in September 2025, and the company filed a counterclaim for NIS 20 million for court-fee purposes in January 2026. This is not the core of Beit Gil Hazahav's current economics, but it is legal and financial noise that will continue to sit above the story.

2025: the house is fuller, but not all of it is permanent residents

Efficiency, Profitability And Competition

What actually improved

The 2025 operating story is a mix of volume, pricing and mix. On volume, average occupancy rose to 75% and the number of occupied units at year end rose to 276 from 212 at the end of 2024. On pricing, average monthly payment per unit rose to NIS 10,038 from NIS 9,046, while average monthly payment in contracts signed during the period rose to NIS 11,616 from NIS 10,785. On mix, more residents moved to the monthly route, and the company also points to the independent operation of the restaurant.

You can see that directly in margins. Cost of revenue rose more slowly than revenue, reaching NIS 27.9 million versus NIS 23.2 million, so gross profit rose to NIS 20.9 million. G&A barely moved, NIS 10.5 million versus NIS 10.6 million, so a large portion of the top-line improvement flowed through to operating profit. Beit Gil Hazahav's NOI also rose to NIS 17.3 million from NIS 13.3 million, while the actual yield rose to 6.91% from 5.69%.

One point that is easy to miss sits below net profit. In 2025 the company recorded NIS 11.6 million of other expense, driven by a lower estimate of the unguaranteed future consideration from the Seven Stars sale. That is why the NIS 11.6 million FFO figure gives a cleaner picture of the operating year than the NIS 7.3 million total net profit.

Where the quality of the jump is still not clean

This is where the single most important detail sits. 2025 proved that Beit Gil Hazahav can fill up. It still has not proved that all of this occupancy rests on stable, high-quality assisted-living contracts. The company itself says that during the year it occupied about 59 units on average, about 20% of the inventory, with tenants who were not permanent assisted-living residents. Revenue from that source was NIS 2.7 million. That is not immaterial, but it is also not the same economic quality as a permanent resident who enters on a longer contract structure.

The cost base also reminds readers of that point. Selling and marketing expense rose to NIS 3.9 million from NIS 3.2 million, partly because of the advertising campaign designed to improve occupancy. So part of the recovery was bought through heavier marketing effort, not only through naturally improving demand.

In competition, Golden House does benefit from its Tel Aviv location and from operating the entire service stack itself, including the nursing layer, rather than outsourcing core functions. That matters because it creates service continuity and more control over resident experience. But this is also an increasingly competitive market. The company identifies Mashan as the main nearby competitor and also points to Migdaley Hayam Hatechon in Bat Yam, Ahuzat Rishonim, Ahuzat Neve Hof and Beit Balev Tel Aviv Haketana. It also notes that larger groups such as Shapir, Israel Canada and Big have already entered the space.

The commercial layer adds some stability, but does not change the thesis by itself. Space in the first floor and ground floor is leased, among others, to Israel Post, Maccabi and Meuhedet, and the company's annual rent from these areas stands at about NIS 3.8 million. At the same time, the company says no single tenant accounts for 10% or more of group revenue. So this is a cushion, not an alternative growth engine.

Permanent occupancy is rising alongside monthly pricing
2025 revenue mix

Cash Flow, Debt And Capital Structure

Precision matters here. I am using an all-in cash-flexibility frame, because the central question at Golden House is not how much cash the business might theoretically generate before capital uses, but how much flexibility really remained after the decisions already taken in practice.

2025 cash flow improved operationally, but the distribution year emptied the cash pile

Cash flow from operations reached NIS 12.1 million in 2025, versus NIS 27.8 million in 2024. That decline does not necessarily signal a weaker Beit Gil Hazahav core. It mainly reflects the fact that 2024 still included receipts related to the England activity. Against that, the company invested NIS 3.6 million in investment property and NIS 1.7 million in fixed assets. So before capital-allocation and financing decisions, the ongoing business still generated modest but positive cash.

The real story sits in the financing layer. During the year, the company paid a NIS 195 million dividend and repaid NIS 56.2 million of bonds. That is why cash and cash equivalents fell from NIS 327.5 million to NIS 81.8 million. So it would be wrong to look at the end-2025 cash balance and say the company "weakened on cash flow." The more accurate reading is that management chose to return a large portion of 2024 monetization proceeds to shareholders, and the remaining platform now has to prove itself on the basis of current operations and one asset.

Where the cash went in 2025

Debt is far from pressure, but the value is still not fully free

On traded debt, the picture is relatively calm. At the end of 2025 the company held NIS 81.8 million of cash and NIS 17.9 million of marketable securities, against NIS 63.7 million of bonds outstanding. Current bond maturities stood at NIS 49.35 million. The covenant picture is also wide open rather than tight: equity stood at NIS 271 million versus a floor of NIS 140 million, and the cash-to-financial-debt ratio stood at 156% versus a 5% minimum. This is not a refinancing-stress story.

But even here it is important to separate financial debt from accessible value. The asset is still pledged into the Bank Hapoalim framework of guarantees, collateral and covenants for the company and Yetzlaf. The historical bank loans have been fully repaid, but a resident bank-guarantee framework of about NIS 25 million is still in place, and about NIS 21 million was utilized at year end. In addition, the property-level banking covenants still require minimum equity of 20% of the balance sheet and at least NIS 150 million, as well as a debt-to-property-value ratio below 75%. The company is in compliance, but the asset is not completely free.

The value looks high, but it still has to pass through deposits, Koptash and one-asset concentration

This is one of the easiest places to misread the company. The appraisal put the value of Beit Gil Hazahav and the additional spaces at NIS 272.3 million, while net property value after deducting resident deposits stood at NIS 250.9 million. That is a large number relative to a market cap of about NIS 163 million. But this is not a simple economic identity.

First, 20% of the building and public areas are tied to the Koptash lease structure. Second, the deposits are smaller than property value, but they are still a real obligation. Third, the entire company now rests on one material asset, so any market discount also reflects concentration, liquidity limits, execution risk and dependence on the quality of permanent occupancy.

The balance sheet is cleaner, but still highly concentrated

Forward View

This section needs to start with four non-obvious findings, because without them it is easy to read 2025 too shallowly.

First finding: the recovery is real, but it is still not clean. The rise in revenue, NOI and monthly pricing is a strong data point, but 2025 still depended meaningfully on non-permanent occupancy.

Second finding: Golden House's problem today is not refinancing risk. The balance sheet is reasonable, cash covers the near-term maturities, and the covenants are nowhere near pressure. The test has shifted from survival to capital allocation.

Third finding: part of the company's value is accounting and asset value, not necessarily directly accessible value. Koptash, resident deposits, pledges and the fact that this is now a one-asset company explain why the market does not automatically pay book value.

Fourth finding: 2026 currently looks more like a bridge and proof year than a breakout year. The test is double: push permanent occupancy above 90% without relying on temporary fill, and show what the company wants to be after the giant distribution.

That is why the next 2 to 4 quarters are relatively easy to define. First, permanent resident occupancy has to keep moving up, not just total occupancy. If the permanent base does not progress toward the sector norm, the market will treat 2025 as a one-year recovery rather than a real change of level. Second, management needs to show that the strategy reset is more than a list of directions. As long as the committee speaks broadly about healthcare, senior living and real estate, the market will keep applying a discount to that optionality.

There is also genuine economic upside embedded in the land. The property still has about 1,660 square meters of unused building rights, and the updated strategy explicitly discusses improving zoning and rights. But this is not yet a clean near-term catalyst. In January 2026, Outline Plan TA 5500 was deposited, and the company says it intends to object because it believes the plan harms the property's value. So the land-rights upside still has to pass through planning, regulation and time.

The market will probably focus on three questions in the near term. Does permanent occupancy keep rising even as the company reduces bridge-type occupancy. Does the end-2025 cash cushion remain strong enough after the near-term maturities. And does the strategy committee turn excess balance-sheet optionality into a believable plan, or open another cycle of uncertainty.

The numbers that stand out on first read

Risks

The first and clearest risk is single-asset dependence. The company itself identifies this as one of its unique risks, and correctly so. Any operating, regulatory, competitive or reputational issue at Beit Gil Hazahav hits almost every layer of value at once.

The second risk is that current occupancy proves lower quality than the first glance suggests. As long as a material part of occupancy still comes from non-permanent fill, the question is not only how many units are occupied, but on what terms, for how long, and what happens when the company tries to replace that bridge with cleaner permanent contracts.

The third risk is regulatory and operational. The company still has not received an operating license under the assisted-living law, although it notes that licenses have not yet been issued to operators across the market. The nursing department does hold a private-hospital registration valid through May 15, 2026 for 36 beds. So the nursing layer is operating on a regulated basis, but it still depends on renewal and continued compliance with Ministry of Health standards.

The fourth risk is structural. The Koptash lease runs until the end of 2033, but from the cut-off date the company is no longer supposed to sign new residents into Koptash rooms, except under temporary extensions that now run through June 30, 2026. That is another reason why the quality of current occupancy matters so much. Not every room in the house produces the same economics for common shareholders.

The fifth risk is legal and planning-related. The Seven Stars lawsuit remains open, and although the company made no provision because legal counsel believes the claim is more likely to be rejected, the issue still represents uncertainty. At the same time, the company believes TA 5500, deposited in January 2026, could damage the property's value beyond what has already been considered. Again, this is not the kind of risk that breaks the company tomorrow morning, but it absolutely affects how readers should think about the land-rights option.


Conclusions

Golden House exits 2025 with genuine good news: Beit Gil Hazahav is improving operationally, pricing is higher, NOI rose sharply, and the balance sheet is not under pressure even after a massive distribution. The main block is that the improvement is still not fully clean, because part of it rests on non-permanent occupancy, while the company's next strategic chapter has not yet been translated into a clear capital-allocation plan.

That is also what should drive the market reading in the short to medium term. The question is no longer survival. The question is whether 2025 was a true return to track, or only a bridge between an old monetization cash pile and a new story that still has not been built.

MetricScoreExplanation
Overall moat strength3.0 / 5Tel Aviv location, an established brand and full in-house service delivery support the property, but there is no scale advantage or diversification
Overall risk level3.5 / 5One asset, material temporary occupancy, Koptash, regulation and weak trading liquidity create real friction
Value-chain resilienceMediumService continuity is strong and the resident base is contractual, but the company depends on one asset and normal resident churn
Strategic clarityMedium-lowThe strategy committee exists, but for now there are only broad directions rather than a concrete capital plan
Short-interest stance0.00% short float, negligible trendThere is no technical attack here. The debate is about recovery quality and accessible shareholder value

Current thesis in one line: Golden House proved in 2025 that the Tel Aviv asset can recover, but 2026 has to prove that the recovery can rest on permanent residents and disciplined capital allocation rather than on bridge occupancy and paper value.

What changed versus the older understanding of the company is now clear: it is no longer read through England and Seven Stars monetizations, but through the question of whether Beit Gil Hazahav can stand on its own as a one-asset public company. The strongest counter-thesis says the market is too harsh, because the company still holds NIS 270.8 million of equity, NIS 250.9 million of net property value, NIS 81.8 million of cash and NIS 17.9 million of securities, so if permanent occupancy keeps rising the market discount may prove too deep.

What could change the market's interpretation over the next few quarters is the combination of three things: the pace of permanent-occupancy improvement, the strategy committee's capital-allocation decisions, and the way the company gets through 2026 without eroding the flexibility left after the 2025 distribution. That matters because in a one-asset assisted-living company, real shareholder value is not defined only by an appraisal. It is defined by the ability to turn occupancy, deposits and cash flow into a stable asset base that truly belongs to common shareholders.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction
Follow-ups
Additional reads that extend the main thesis